tadalafil has been researched along with Body Weight in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferguson-Sells, L; Li, B; Small, D; Velez de Mendizabal, N | 1 |
| Baseskioglu, AB; Erol, K; Ozatik, FY; Ozatik, O; Sirmagul, B; Yigitaslan, S | 1 |
| Nna, VU; Osim, EE | 1 |
| Das, A; Durrant, DE; Hoke, NN; Kukreja, RC; Salloum, FN; Varma, A | 1 |
1 trial(s) available for tadalafil and Body Weight
| Article | Year |
|---|---|
Population Pharmacokinetics of Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension: A Combined Adult/Pediatric Model.
Topics: Adult; Area Under Curve; Body Weight; Bosentan; Child; Female; Humans; Male; Pulmonary Arterial Hypertension; Tadalafil | 2022 |
3 other study(ies) available for tadalafil and Body Weight
| Article | Year |
|---|---|
Effects of tadalafil on hemorrhagic cystitis and testicular dysfunction induced by cyclophosphamide in rats.
Topics: Animals; Antioxidants; Body Weight; Carbolines; Cyclic GMP; Cyclophosphamide; Cystitis; Follicle Stimulating Hormone; Immunohistochemistry; Interleukin-10; Interleukin-6; Luteinizing Hormone; Male; Nitric Oxide; Organ Size; Rats; Rats, Sprague-Dawley; Sperm Count; Tadalafil; Temperature; Testis; Testosterone; Urological Agents | 2014 |
Testicular toxicity following separate and combined administration of PDE5 inhibitors and opioid: assessment of recovery following their withdrawal.
Topics: Analgesics, Opioid; Animals; Body Weight; Catalase; Glutathione; Glutathione Peroxidase; Lipid Peroxidation; Male; Malondialdehyde; Organ Size; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Rats; Rats, Wistar; Sperm Motility; Superoxide Dismutase; Tadalafil; Testis; Tramadol | 2017 |
Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice.
Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Mellitus, Experimental; Drug Administration Schedule; Fasting; Interleukin-1beta; Male; Mice; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Necrosis; Obesity; Phosphodiesterase Inhibitors; Receptors, Leptin; Tadalafil; Triglycerides; Tumor Necrosis Factor-alpha | 2012 |